EDGAR Filing Documents for 0001140361-17-040667

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001140361-17-040667

Filing Date

2017-11-02

Accepted

2017-11-02 11:50:25

Documents

Period of Report

2017-11-01

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	doc1.html	4
1	FORM 4	doc1.xml	4	3990
	Complete submission text file	0001140361-17-040667.txt		5455

Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631

Business Address

Type: 4 | Act: 34 | File No.: 001-38155 | Film No.: 171171332

Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362

Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256

Sienna Biopharmaceuticals, Inc. (Issuer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations